Johnson & Johnson announced on 1st July 2020 that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen developed in partnership with Bavarian Nordic for the prevention of Ebola Virus Disease. The full press release can be found HERE.